04/05/2022
RSV causes lung and respiratory tract infections and is highly contagious, there is no effective vaccine or cure for it. The virus is usually not serious for adults and older children but infants and premature babies can become very sick. Pfizer is carrying out the vaccine trial, which is currently in phase three and is given to pregnant women rather than the baby.
Read more
08/03/2022
The requests for Middlemore Clinical Trials to be involved in clinical trials has never been greater.
Read more
02/03/2022
March is Kidney Health month, which is an opportunity to highlight the great work the Renal department does for the Counties Manukau catchment.
Read more
09/12/2021
The Haematology department at Middlemore Hospital are unique in that all six consultants are actively involved in clinical research. The team are very busy with a combination of commercial and grant-funded trials as well as their clinic responsibilities.
Read more
10/11/2021
We are proud to have coordinated this first-in-human-open label clinical study with Principal Investigator Mr Jon Mathy in Plastic surgery and Mr Alpesh Patel in Spinal surgery.
Read more
18/10/2021
Middlemore Clinical Trials is pleased to present our Annual Report 2021.
Read more
01/10/2021
The AustralaSian COVID-19 Trial, is a multi-centre randomised adaptive platform clinical trial to assess clinical, virological, and immunological outcomes in patients with SARS-CoV-2 infection (COVID-19). The New Zealand arm of the study is led by CM Health clinical microbiologist and infectious disease consultant, Dr Susan Morpeth.
Read more
31/03/2021
CM Health ophthalmologist and new researcher to MMCT, Dr Rasha Al Taie, has recently been successful in receiving funding from the Potters Masonic Trust, with help from our grants team, for a study investigating the early detection of keratoconus through artificial intelligence.
Read more
03/12/2020
Dr Jon Mathy is a researcher and plastic surgeon, who has been with Middlemore Hospital since 2010. He has a huge desire to improve patient care, particularly surrounding wound healing and management of surgical site infections. Dr Mathy and his co-collaborators have recently been awarded a research activation grant from the New Zealand Health Research Council (HRC) as an initial investigation into the use of anti-staphylococcal bundles in reducing post-IBBR SSIs.
Read more
10/11/2020
We are pleased to announce the formal opening of our infusion suite at Middlemore Clinical Trials with the advent of a karakia (blessing) and the bestowing of a Te Reo Māori name on the suite.
Read more
17/09/2020
Middlemore Clinical Trials is pleased to present our Annual Report 2020.
Read moreMiddlemore Clinical Trials is a fully integrated research unit based at Middlemore Hospital in the heart of South Auckland, New Zealand.
We perform biopharma and medical device clinical trials in partnership with all hospital departments focusing on the diseases and Long term health conditions that affect our diverse community.
